Skip to content
Governance Register

← US public companies

Maynard Ryan D

SEC-identified person · CIK 1363984 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Lion Biotechnologies, Inc. N/A Director filed 2015–2026
Foghorn Therapeutics Inc. FHTX Chief Financial Officer filed 2026–2026
Tvardi Therapeutics, Inc. TVRD Chief Financial Officer filed 2022–2024
Rigel Pharmaceuticals INC RIGL VP, CFO filed 2006–2017

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.